Financial News
Articles published by XBiotech Inc.
   
    XBiotech Pauses Rheumatology program
    
   December 23, 2024
   From XBiotech Inc.
   Via GlobeNewswire
    Tickers
      XBIT
    
   
   
   From XBiotech Inc.
   Via GlobeNewswire
    Tickers
      XBIT
    
   
   From XBiotech Inc.
   Via GlobeNewswire
    Tickers
      XBIT
    
   
   
    XBiotech Announces Enrollment Completion of Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke
    
   September 26, 2023
   From XBiotech Inc.
   Via GlobeNewswire
    Tickers
      XBIT
    
   
   
   
   From XBiotech Inc.
   Via GlobeNewswire
    Tickers
      XBIT
    
   
   From XBiotech Inc.
   Via GlobeNewswire
    Tickers
      XBIT
    
   
   
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
